AGA
Altrinsic Global Advisors Portfolio holdings
AUM
$2.76B
This Quarter Return
-1.39%
1 Year Return
+17.53%
3 Year Return
+48.92%
5 Year Return
+91.21%
10 Year Return
+153.34%
AUM
$3.34B
AUM Growth
+$3.34B
(+1.5%)
Cap. Flow
+$125M
Cap. Flow
% of AUM
3.75%
Top 10 Holdings %
Top 10 Hldgs %
58.49%
Holding
82
New
2
Increased
32
Reduced
32
Closed
3
Top Buys
| 1 |
Willis Towers Watson
WTW
|
$234M |
| 2 |
Trip.com Group
TCOM
|
$44.8M |
| 3 |
Credicorp
BAP
|
$37.2M |
| 4 |
Liberty Global Class A
LBTYA
|
$21.5M |
| 5 |
Kinross Gold
KGC
|
$16.3M |
Top Sells
| 1 |
Aon
AON
|
$132M |
| 2 |
Ambev
ABEV
|
$59M |
| 3 |
Exelon
EXC
|
$26.7M |
| 4 |
Oracle
ORCL
|
$21.1M |
| 5 |
Kroger
KR
|
$16.2M |
Sector Composition
| 1 | Financials | 34.68% |
| 2 | Communication Services | 16.9% |
| 3 | Technology | 11.43% |
| 4 | Consumer Discretionary | 11.18% |
| 5 | Healthcare | 10.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Elevance Health
ELV
$71.8B
| $3.77M | 0.11% |
10,100
+2,000
| +25% | +$746K |
|
|
JWN
52
DELISTED
Nordstrom
JWN
| $3.65M | 0.11% |
138,092
-6,373
| -4% | -$169K |
|
53
Gilead Sciences
GILD
$140B
| $3.14M | 0.09% |
45,000
-45,000
| -50% | -$3.14M |
|
|
AERI
54
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $3.08M | 0.09% |
270,000
+30,000
| +13% | +$342K |
|
|
ITCI
55
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.98M | 0.09% |
80,000
+20,000
| +33% | +$746K |
|
56
Lantheus
LNTH
$3.73B
| $2.83M | 0.08% |
110,000
-20,000
| -15% | -$514K |
|
57
Brookdale Senior Living
BKD
$1.83B
| $2.79M | 0.08% |
442,452
| – | – |
|
58
Jazz Pharmaceuticals
JAZZ
$7.75B
| $2.73M | 0.08% |
21,000
+6,000
| +40% | +$781K |
|
59
ProQR Therapeutics
PRQR
$237M
| $2.69M | 0.08% |
321,360
| – | – |
|
60
Xenon Pharmaceuticals
XENE
$2.98B
| $2.6M | 0.08% |
170,000
| – | – |
|
|
ICPT
61
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $2.51M | 0.08% |
168,800
| – | – |
|
62
Envista
NVST
$3.52B
| $2.09M | 0.06% |
50,000
| – | – |
|
63
Kura Oncology
KURA
$686M
| $2.06M | 0.06% |
110,000
+20,000
| +22% | +$375K |
|
64
Axogen
AXGN
$743M
| $2.05M | 0.06% |
130,000
+20,000
| +18% | +$316K |
|
65
Sangamo Therapeutics
SGMO
$157M
| $1.95M | 0.06% |
216,500
| – | – |
|
66
Atara Biotherapeutics
ATRA
$84.6M
| $1.79M | 0.05% |
100,000
+10,000
| +11% | +$179K |
|
67
Fate Therapeutics
FATE
$120M
| $1.6M | 0.05% |
27,000
-3,000
| -10% | -$178K |
|
68
MacroGenics
MGNX
$112M
| $1.47M | 0.04% |
70,000
| – | – |
|
69
Cabaletta Bio
CABA
$133M
| $1.46M | 0.04% |
120,000
-10,000
| -8% | -$122K |
|
|
AGTC
70
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $1.13M | 0.03% |
376,900
| – | – |
|
71
JD.com
JD
$44.1B
| $1.1M | 0.03% |
15,153
-95
| -0.6% | -$6.87K |
|
72
Tenaris
TS
$18.9B
| $923K | 0.03% |
43,734
-271
| -0.6% | -$5.72K |
|
73
Kezar Life Sciences
KZR
$28.9M
| $864K | 0.03% |
100,000
| – | – |
|
74
Infosys
INFY
$69.7B
| $851K | 0.03% |
38,267
-6,827
| -15% | -$152K |
|
75
Delcath Systems
DCTH
$385M
| $835K | 0.03% |
80,000
| – | – |
|